1,2-dipalmitoylphosphatidylcholine has been researched along with resiquimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barinaga, G; Carter, D; King, DF; Mann, JF; McKay, PF; Shattock, RJ | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and resiquimod
Article | Year |
---|---|
TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Administration, Intranasal; AIDS Vaccines; Animals; Antibody Affinity; Antibody Specificity; Antigens; Dose-Response Relationship, Immunologic; Drug Combinations; env Gene Products, Human Immunodeficiency Virus; Female; HIV Antibodies; Imidazoles; Immunity, Innate; Immunity, Mucosal; Immunization, Secondary; Immunoglobulin G; Injections, Intradermal; Lipid A; Models, Animal; Nasal Mucosa; Neutralization Tests; Organ Specificity; Swine; Swine, Miniature; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Vaccination; Vagina | 2016 |